A novel model for Ki67 assessment in breast cancer

ABSTRACT: BACKGROUND: Ki67 is currently the proliferation biomarker of choice, with both prognostic and predictive value in breast cancer. A lack of consensus regarding Ki67 use in pre-analytical, analytical and post-analytical practice may hinder its formal acceptance in the clinical setting. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Quinci, Bendahl, Pär-Ola, Fernö, Mårten, Grabau, Dorthe, Borgquist, Signe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069280/
https://www.ncbi.nlm.nih.gov/pubmed/24934660
http://dx.doi.org/10.1186/1746-1596-9-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069280/
https://www.ncbi.nlm.nih.gov/pubmed/24934660
http://dx.doi.org/10.1186/1746-1596-9-118

Ejemplares similares